OMERS Administration Corp’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

OMERS Administration Corp’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-86,300	Closed	-$967K	–	518
2017 Q3	$967K	Buy	86,300 +7,800	+10%	+$86K	0.01%	286
2017 Q2	$864K	Buy	+78,500	New	+$785K	0.01%	332
2017 Q1	–	Sell	-52,400	Closed	-$566K	–	429
2016 Q4	$566K	Buy	+52,400	New	+$524K	0.01%	219
2016 Q2	–	Sell	-39,200	Closed	-$431K	–	703
2016 Q1	$431K	Buy	+39,200	New	+$349K	0.01%	442

OMERS Administration Corp's SCLN Position: Q4 2017 in Review

OMERS Administration Corp sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 86,300 shares — an estimated $967K sold.

OMERS Administration Corp first reported a position in SCLN in Q1 2016 and held it in 4 quarters. The position peaked at $967K in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

OMERS Administration Corp reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
OMERS Administration Corp sold 86,300 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $967K.
OMERS Administration Corp first reported a position in Sciclone Pharmaceuticals Inc in Q1 2016 and held it in 4 quarters.
OMERS Administration Corp's Sciclone Pharmaceuticals Inc position peaked at $967K in Q3 2017.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on OMERS Administration Corp's 13F filing for Q4 2017, filed 13 Feb 2018.